These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 26085051)
1. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate. Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
3. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations. Salama AH; Mahmoud AA; Kamel R AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410 [TBL] [Abstract][Full Text] [Related]
4. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Morsi N; Ghorab D; Refai H; Teba H Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293 [TBL] [Abstract][Full Text] [Related]
5. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178 [TBL] [Abstract][Full Text] [Related]
6. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Patel N; Nakrani H; Raval M; Sheth N Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408 [TBL] [Abstract][Full Text] [Related]
7. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium. Arafa MG; Girgis GNS; El-Dahan MS Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin. Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983 [TBL] [Abstract][Full Text] [Related]
9. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. He W; Guo X; Feng M; Mao N Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520 [TBL] [Abstract][Full Text] [Related]
11. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study. Singh J; Chhabra G; Pathak K Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522 [TBL] [Abstract][Full Text] [Related]
12. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Ahmed TA; Aljaeid BM Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
14. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil. Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982 [TBL] [Abstract][Full Text] [Related]
15. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related]
16. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel. Khan S; Warade S; Singhavi DJ J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593 [TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid. Jhawat V; Gupta S; Saini V Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650 [TBL] [Abstract][Full Text] [Related]
18. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
19. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Ahmed TA; El-Say KM Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393 [TBL] [Abstract][Full Text] [Related]
20. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab. Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]